210 related articles for article (PubMed ID: 32539632)
1. Vascular effects of cancer treatments.
Campia U
Vasc Med; 2020 Jun; 25(3):226-234. PubMed ID: 32539632
[TBL] [Abstract][Full Text] [Related]
2. In Development-A New Paradigm for Understanding Vascular Disease.
Flavahan NA
J Cardiovasc Pharmacol; 2017 May; 69(5):248-263. PubMed ID: 28328747
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular oncology: exploring the effects of targeted cancer therapies on atherosclerosis.
Seijkens TTP; Lutgens E
Curr Opin Lipidol; 2018 Oct; 29(5):381-388. PubMed ID: 30074493
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms for vascular complications of targeted cancer therapies.
Gopal S; Miller KB; Jaffe IZ
Clin Sci (Lond); 2016 Oct; 130(20):1763-79. PubMed ID: 27612952
[TBL] [Abstract][Full Text] [Related]
5. Vascular Complications of Cancer Chemotherapy.
Cameron AC; Touyz RM; Lang NN
Can J Cardiol; 2016 Jul; 32(7):852-62. PubMed ID: 26968393
[TBL] [Abstract][Full Text] [Related]
6. Vascular Toxicity in Patients with Cancer: Is There a Recipe to Clarify Treatment?
Alvarez-Cardona J; Mitchell J; Lenihan D
Methodist Debakey Cardiovasc J; 2019; 15(4):289-299. PubMed ID: 31988690
[TBL] [Abstract][Full Text] [Related]
7. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk.
Wang X; Keith JC; Struthers AD; Feuerstein GZ
Cardiovasc Ther; 2008; 26(3):214-23. PubMed ID: 18786091
[TBL] [Abstract][Full Text] [Related]
8. Vascular toxicity of chemotherapeutic agents.
López-Miranda V; Herradón E; González C; Martín MI
Curr Vasc Pharmacol; 2010 Sep; 8(5):692-700. PubMed ID: 19758112
[TBL] [Abstract][Full Text] [Related]
9. Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review.
Keefe D; Bowen J; Gibson R; Tan T; Okera M; Stringer A
Oncologist; 2011; 16(4):432-44. PubMed ID: 21441297
[TBL] [Abstract][Full Text] [Related]
10. Arterial Thrombotic Complications of Tyrosine Kinase Inhibitors.
Wu MD; Moslehi JJ; Lindner JR
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):3-10. PubMed ID: 33275447
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular toxic effects of antitumor agents: Pathogenetic mechanisms.
Pantazi D; Tselepis AD
Thromb Res; 2022 May; 213 Suppl 1():S95-S102. PubMed ID: 36210569
[TBL] [Abstract][Full Text] [Related]
12. Cancer Therapy-Associated Thrombosis.
Grover SP; Hisada YM; Kasthuri RS; Reeves BN; Mackman N
Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1291-1305. PubMed ID: 33567864
[TBL] [Abstract][Full Text] [Related]
13. Update of Targeted Therapy-Induced Hypertension: Basics for Non-Oncology Providers.
Escalante CP; Lu M; Marten CA
Curr Hypertens Rev; 2016; 12(2):112-20. PubMed ID: 26931476
[TBL] [Abstract][Full Text] [Related]
14. Common Vascular Toxicities of Cancer Therapies.
Herrmann J
Cardiol Clin; 2019 Nov; 37(4):365-384. PubMed ID: 31587779
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.
Maurea N; Coppola C; Piscopo G; Galletta F; Riccio G; Esposito E; De Lorenzo C; De Laurentiis M; Spallarossa P; Mercuro G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S19-26. PubMed ID: 27183521
[TBL] [Abstract][Full Text] [Related]
16. Vascular complications of selected cancer therapies.
Daher IN; Yeh ET
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):797-805. PubMed ID: 18852710
[TBL] [Abstract][Full Text] [Related]
17. [Prophylaxis of thrombosis induced by chemotherapy or central venous catheters].
Voog E; Lazard E; Juhel L
Presse Med; 2007 Feb; 36(2 Pt 1):225-34. PubMed ID: 17259031
[TBL] [Abstract][Full Text] [Related]
18. Management of pulmonary toxicity associated with targeted anticancer therapies.
Teuwen LA; Van den Mooter T; Dirix L
Expert Opin Drug Metab Toxicol; 2015; 11(11):1695-707. PubMed ID: 26293379
[TBL] [Abstract][Full Text] [Related]
19. Vascular toxicity of antineoplastic agents.
Shahab N; Haider S; Doll DC
Semin Oncol; 2006 Feb; 33(1):121-38. PubMed ID: 16473650
[TBL] [Abstract][Full Text] [Related]
20. Vascular toxicity associated with antineoplastic agents.
Doll DC; Yarbro JW
Semin Oncol; 1992 Oct; 19(5):580-96. PubMed ID: 1411655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
